Literature DB >> 34523037

Exposure-lag-response associations between extreme environmental conditions and primary Sjögren's syndrome.

Ling Xin1, Yongjian Zhu2, Jian Liu3, Yanyan Fang1, Jingui Xie4.   

Abstract

INTRODUCTION: Patients with primary Sjögren's syndrome (pSS) reportedly believe that their symptoms worsen on extreme weather days due to variations in environmental conditions. However, few studies have assessed the acute effects of environmental exposure on the onset of pSS. This study aimed to evaluate the exposure-response relationship between extreme environmental conditions and pSS outpatient visits.
METHOD: We obtained data on pSS outpatient visits from two provincial general hospitals in Hefei, China, during 2014-2019. A distributed lag non-linear model was used to estimate the exposure-lag-response relationship between environmental variables and pSS.
RESULTS: We detected significant and non-linear associations between extreme environments and pSS. The estimated relative risk (RR) for a lag of 3 days was 1.11 (95% CI: 1.03 to 1.19) for extreme cold and for a lag of 21 days was 1.07 (95% CI: 1.01 to 1.12) for extreme dampness. Long sunshine duration was positively correlated with pSS (lag 11, 1.05, 95% CI: 1.01 to 1.08). Moreover, female patients were more susceptible to these effects. Patients older than 65 years old were more vulnerable to frigid environments (lag 3, RR = 1.30, 95% CI: 1.09 to 1.54), while younger patients were more vulnerable to extreme dampness (lag 21, RR = 1.10, 95% CI: 1.03 to 1.16). Extreme cold and high humidity were negatively correlated with the same-day outpatient visits.
CONCLUSIONS: Our findings suggest a potential relationship between exposure to extreme environmental conditions and increased risk of pSS outpatient visits. We therefore suggest that policymakers and doctors aim to further our understanding of environmental effects on pSS and adopt adequate measures to alleviate pSS symptoms. Key Points • Extreme cold, extreme dampness, and long sunshine duration increased the risk of pSS outpatient visits, especially for females. • Young pSS patients are more susceptible to a rise in humidity. • Elderly pSS patients are more sensitive to extreme cold weather.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Distributed-lag nonlinear model; Extreme cold; Extreme damp; Long sunshine duration; Outpatient visit; Primary Sjögren’s syndrome

Mesh:

Year:  2021        PMID: 34523037     DOI: 10.1007/s10067-021-05910-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

1.  Xerosis in primary Sjögren syndrome: immunohistochemical and functional investigations.

Authors:  E Bernacchi; B Bianchi; L Amato; S Giorgini; P Fabbri; A Tavoni; S Bombardieri
Journal:  J Dermatol Sci       Date:  2005-07       Impact factor: 4.563

2.  Photoprovocation test and immunohistochemical analysis of inducible nitric oxide synthase expression in patients with Sjögren's syndrome associated with photosensitivity.

Authors:  N Tsukazaki; M Watanabe; K Shimizu; Y Hamasaki; I Katayama
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

Review 3.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

4.  Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS).

Authors:  Camille Villon; Laure Orgeolet; Anne-Marie Roguedas; Laurent Misery; Jacques-Eric Gottenberg; Divi Cornec; Sandrine Jousse-Joulin; Raphaele Seror; Jean-Marie Berthelot; Philippe Dieude; Jean-Jacques Dubost; Anne-Laure Fauchais; Vincent Goeb; Eric Hachulla; Pierre-Yves Hatron; Claire Larroche; Gilles Hayem; Véronique Le Guern; Aleth Perdriger; Jacques Morel; Olivier Vittecoq; Xavier Mariette; Valérie Devauchelle-Pensec; Alain Saraux
Journal:  Joint Bone Spine       Date:  2021-02-19       Impact factor: 4.929

5.  Epidemiology and socioeconomic impact of the rheumatic diseases on indigenous people: an invisible syndemic public health problem.

Authors:  Ingris Peláez-Ballestas; Ysabel Granados; Bernardo A Pons-Éstel; Rosana Quintana; Adalberto Loyola-Sánchez; Flor Julián-Santiago; Celenia Rosillo; Alfonso Gastelum-Strozzi; Jose Alvarez-Nemegyei; Natalia Santana; Adriana Silvestre; Cesar Pacheco-Tena; Mario Goñi; Conrado García-García; Ligia Cedeño
Journal:  Ann Rheum Dis       Date:  2018-07-14       Impact factor: 19.103

Review 6.  Renal involvement in primary Sjögren syndrome.

Authors:  Hélène François; Xavier Mariette
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

7.  Cognition, depression, fatigue, and quality of life in primary Sjögren's syndrome: correlations.

Authors:  Belgin Koçer; Mehmet Engin Tezcan; Hale Zeynep Batur; Şeminur Haznedaroğlu; Berna Göker; Ceyla İrkeç; Rümeysa Çetinkaya
Journal:  Brain Behav       Date:  2016-10-13       Impact factor: 2.708

8.  Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.

Authors:  Jie Tian; Yue Hong; Qiugang Zhu; Huimin Zhou; Yidan Zhang; Ziwei Shen; Hongye Guo; Yue Zhang; Xiangyan Ai; Futao Zhao; Ke Rui; Huaxi Xu; Shengjun Wang
Journal:  Front Immunol       Date:  2020-12-22       Impact factor: 7.561

9.  Is it possible to not perform salivary gland biopsy in targeted patients according to unstimulated salivary flow results in patients with suspected Sjögren's syndrome?

Authors:  Agata Sebastian; Patryk Woytala; Marta Madej; Krzysztof Proc; Katarzyna Czesak-Woytala; Maciej Sebastian; Krzysztof Zub; Piotr Wiland
Journal:  Rheumatol Int       Date:  2021-04-12       Impact factor: 2.631

10.  Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndrome.

Authors:  Pierre-Marie Duret; Nicolas Meyer; Alain Saraux; Valérie Devauchelle-Pensec; Raphaele Seror; Véronique Le-Guern; Claire Larroche; Aleth Perdriger; Jean Sibilia; Vianney Guardiolle; Xavier Mariette; Jacques-Eric Gottenberg
Journal:  Arthritis Res Ther       Date:  2020-02-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.